This month, the Centers for Medicare & Medicaid Services announced the first wave of tools and partnerships under its Health Tech Ecosystem initiative — including the novel Medicare App Library
Wisp, Visby Partner to Expand Access to At-Home STI Test
Wisp, a women’s telehealth company, launched a partnership with Visby Medical on Thursday to increase access to Visby’s at-home polymerase chain reaction (PCR) test for sexually transmitted infections. New York
The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease
Alzheimer’s disease continues to be one of the most daunting public health challenges of our time. In the United States alone, one in nine people over age 65 is living
Why Innovaccer Is Pouring $250M into Its Agentic AI Platform
Healthcare AI company Innovaccer announced on Wednesday that it is committing $250 million over the next three years to build out its platform of AI agents, which perform tasks across
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Rep. Greg Murphy (R-North Carolina) introduced the Every Dollar Counts Act on Tuesday. It would ensure out-of-pocket costs for covered prescription drugs are applied toward patients’ deductibles and maximum out-of-pocket
Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this space is the acquisition of CrossBridge Bio, a preclinical startup
Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft
AI-powered cardiac imaging company HeartFlow sued its competitor Cleerly this week, claiming the company infringed on its patents and misused proprietary technology to build a competing platform. The lawsuit, filed
Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care
Vida Health, a virtual cardiometabolic care provider, is partnering with wearable device company ŌURA to integrate ŌURA’s biometric data into Vida’s clinical programs, the companies announced on Tuesday. Vida offers
Why Synthetic Data is the Antidote to Clinical Trials
Medical device innovation is laborious because of the high bar for validating that the technology does no harm. Patient recruitment for statistically powered trials stretches timelines and drives validation costs
Report: Growth in MA Is Associated With Lower Total Medicare Spending
Enrollment in Medicare Advantage has steadily increased over the past two decades. The number of MA enrollees grew from about 11 million (25% of total Medicare beneficiaries) in 2010 to









